Followers | 17 |
Posts | 2086 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
Thursday, September 26, 2024 9:23:14 PM
Did you see where I sold part of my NVAX holdings on the latest news and bought back $1.50 lower and gained $9,425 worth of FREE Novavax shares? Lowered my average cost basis from $5.63/share to $5.41 in the process. That's what some claim to be doing on the MONI board. So how are their actions not a P&D but mine are?
Novavax has a short-seller problem. The overall percentage of shares shorted has been heading lower for months, currently around 20-22% of outstanding shares. I don't short stocks and I don't buy on margin. Myself and some other NVAX investors are trying to take advantage of shorting presence by trading a little on the price swings created by these shorts. That's not illegal, and it's not pumping and dumping as you seem to believe. My outlook on Novavax has always been positive, and my outlook doesn't change on a dime like it does with most P&D'ers. Look to your own MONI board for examples.
Educate yourself more and you won't appear uninformed or ignorant in what you post. I'm guessing you don't really care. 🤣
Recent NVAX News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2024 11:00:38 AM
- Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million • PR Newswire (US) • 12/04/2024 07:00:00 AM
- Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 11/15/2024 12:47:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 09:08:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/13/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:08:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 04:21:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:04:48 PM
- Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 11/12/2024 01:02:00 PM
- U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial • PR Newswire (US) • 11/11/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 10:01:06 PM
- Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 • PR Newswire (US) • 11/04/2024 09:30:00 PM
- Åsa Manelius Named Managing Director of Novavax AB Site • PR Newswire (US) • 11/04/2024 11:00:00 AM
- Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial • PR Newswire (US) • 10/16/2024 12:14:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:00:11 PM
- Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU • PR Newswire (US) • 10/09/2024 11:00:00 AM
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development • PR Newswire (US) • 09/25/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:08:16 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. • PR Newswire (US) • 09/13/2024 01:25:00 PM
- Novavax to Participate in Upcoming September Conferences • PR Newswire (US) • 09/04/2024 01:25:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 08:19:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 07:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:47:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:06:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:15:42 PM
North Bay Resources Commences Fran Gold Winter Ore Shipment to Bishop Gold Mill, California • NBRI • Dec 2, 2024 9:07 AM
VAYK Reached Agreement on Terms to Acquire $1 Million Company for Disruptive Airbnb Strategy • VAYK • Dec 2, 2024 9:00 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM
BNCM Announces its Q3 and 9-Month Growth Results for 2024 • BNCM • Nov 26, 2024 7:03 AM